EMCDDA Home
  • EN
Search

EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)

EMCDDA-Europol, Lisbon, January 2014

Publication type:

Joint Reports

Summary:

The EMCDDA–Europol Joint Report on new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that sufficient information had been accumulated to merit the production of a Joint Report on MDPV as stipulated by Article 5.1 of the Decision.

Download as pdf (993Kb):

English (en)

Table of contents

  • Introduction
  • Information collection process
  • Information required by Article 5.2 of the Decision
  • Information from the EMA as requested by Article 5.3 of the Decision
  • Conclusion

Pages:

54

Price:

free

ISBN/ISSN:

978-92-9168-680-3

DOI:

10.2810/24085

Catalogue number:

TDAS14001ENN

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Thursday, 10 April 2014